Debate Over Drug Prices in India, Q&A with Piramal Healthcare CEO

India’s government is facing stiff resistance from foreign and domestic pharmaceutical companies over its plan to limit prices for drugs severely. This video debates the drug prices in India with a Q&A with Piramal Healthcare CEO, Ajay Piramal.

Source: Wall Street Journal. There may be a short advert at the start.

, ,

No comments yet.

Leave a Reply

Read more:
With generics on one side and R&D on the other, where does pharma fit?

I know what your thinking "But pharma does undertake R&D". However drug development expenditures dedicated to in-house core activities declined...